BioCentury | Aug 1, 2020
Management Tracks

Nabel leaves Moderna’s board to avoid conflict-of-interest concerns; plus changes at Genespire, La Jolla, Editas and more

...Moderna’s COVID-19 vaccine, mRNA-1273. Nabel is also a professor of medicine at Harvard Medical School. San Raffaele Telethon Institute for Gene Therapy...
BioCentury | Jun 19, 2020
Management Tracks

Dubovsky succeeds Fries as Novavax CMO; plus Carl June to head Ziopharm SAB, Dewpoint, FerGene, Cambrex, Adverum, Epsilen and more

...raised €2.3 million ($2.6 million) in seed funding from Sofinnova Partners, also partnered with the San Raffaele Telethon Institute for Gene Therapy...
BioCentury | May 21, 2020
Product Development

May 20 Quick Takes: Filgotinib meets in ulcerative colitis; broader labels for Lynparza, Tecentriq, plus updates from Eiger, eGenesis and more

...SR-Tiget to develop a gene therapy for X-linked hyper-IgM syndrome Sofinnova Partners-backed Genespire Inc. and San Raffaele Telethon Institute for Gene Therapy...
...pembrolizumab (MK-3475, lambrolizumab) Gilead Sciences Inc. Galapagos N.V. Merck & Co. Inc. Eiger BioPharmaceuticals Inc. eGenesis Inc. ICB International Sofinnova Partners Surface Oncology Inc. San Raffaele Telethon Institute for Gene Therapy Zentalis...
BioCentury | Apr 30, 2020
Finance

April 29 Quick Takes: After ADC approval, Immunomedics raises $420M for rollout; plus Genespire, Vertex, Ocumension and Cadent

...Fund, closed early this year to invest in Italian biotechs. Genespire, which spun out of San Raffaele Telethon Institute for Gene Therapy...
BioCentury | Apr 20, 2020
Finance

French VC Sofinnova expanding start-up ecosystem in Italy with new local fund’s first investments

...NASDAQ:ORTX), the first ex vivo gene therapy to gain European approval, was developed by the San Raffaele Telethon Institute for Gene Therapy...
BioCentury | Sep 12, 2019
Financial News

Genenta’s series C marks start of Qianzhan’s European push

...there are still “great science and skills, and fewer investors.” Genenta spun out from the San Raffaele Telethon Institute for Gene Therapy...
BioCentury | May 28, 2019
Distillery Techniques

Raising lentiviral surface levels of CD47 to improve therapeutic index

...et al. Sci. Transl. Med. ; published online May 22, 2019 doi:10.1126/scitranslmed.aav7325 CONTACT: Alessio Cantore, San Raffaele Telethon Institute for Gene Therapy...
...University, Milan, Italy email: cantore.alessio@hsr.it CONTACT: Luigi Naldini, same affiliation as above email: naldini.luigi@hsr.it Sandi Wong Bioverativ Inc. San Raffaele Telethon Institute for Gene Therapy Sanofi Vita-Salute...
BioCentury | May 24, 2019
Finance

Europe: Some spots hotter than others

...Italian startups based on research coming out of Telethon. The charity’s research institutes include the San Raffaele Telethon Institute for Gene Therapy...
...Italy Harvard University, Cambridge, Mass. Johns Hopkins University, Baltimore, Md. National University of Singapore, Singapore San Raffaele Telethon Institute for Gene Therapy...
...Oxford, Oxford, U.K. Vivet Therapeutics, Paris, France Stephen Hansen, Associate Editor Harvard University Johns Hopkins University National University of Singapore San Raffaele Telethon Institute for Gene Therapy University...
BioCentury | May 22, 2019
Preclinical News

SR-Tiget-led team boosts ‘don’t eat me’ signals on viral vectors to improve efficacy

...acquire the anti-phagocytic signal CD47 from host cell membranes, a team led by researchers at San Raffaele Telethon Institute for Gene Therapy...
...for hemophilia A and B using the institute's lentiviral gene transfer technology. Sandi Wong, Staff Writer Bioverativ Inc. San Raffaele Telethon Institute for Gene Therapy Sanofi CD47 Factor...
BioCentury | Oct 18, 2018
Distillery Therapeutics

Cancer

...G. et al. Nat. Commun. ; published online July 24, 2018 doi:10.1038/s41467-018-05315-0 CONTACT: Bernhard Gentner, San Raffaele Telethon Institute for Gene Therapy...
...Milan, Italy email: gentner.bernhard@hsr.it CONTACT: Luigi Naldini, Vita-Salute San Raffaele University, Milan, Italy email: naldini.luigi@hsr.it Alicia Parker San Raffaele Telethon Institute for Gene Therapy San...
Items per page:
1 - 10 of 25
BioCentury | Aug 1, 2020
Management Tracks

Nabel leaves Moderna’s board to avoid conflict-of-interest concerns; plus changes at Genespire, La Jolla, Editas and more

...Moderna’s COVID-19 vaccine, mRNA-1273. Nabel is also a professor of medicine at Harvard Medical School. San Raffaele Telethon Institute for Gene Therapy...
BioCentury | Jun 19, 2020
Management Tracks

Dubovsky succeeds Fries as Novavax CMO; plus Carl June to head Ziopharm SAB, Dewpoint, FerGene, Cambrex, Adverum, Epsilen and more

...raised €2.3 million ($2.6 million) in seed funding from Sofinnova Partners, also partnered with the San Raffaele Telethon Institute for Gene Therapy...
BioCentury | May 21, 2020
Product Development

May 20 Quick Takes: Filgotinib meets in ulcerative colitis; broader labels for Lynparza, Tecentriq, plus updates from Eiger, eGenesis and more

...SR-Tiget to develop a gene therapy for X-linked hyper-IgM syndrome Sofinnova Partners-backed Genespire Inc. and San Raffaele Telethon Institute for Gene Therapy...
...pembrolizumab (MK-3475, lambrolizumab) Gilead Sciences Inc. Galapagos N.V. Merck & Co. Inc. Eiger BioPharmaceuticals Inc. eGenesis Inc. ICB International Sofinnova Partners Surface Oncology Inc. San Raffaele Telethon Institute for Gene Therapy Zentalis...
BioCentury | Apr 30, 2020
Finance

April 29 Quick Takes: After ADC approval, Immunomedics raises $420M for rollout; plus Genespire, Vertex, Ocumension and Cadent

...Fund, closed early this year to invest in Italian biotechs. Genespire, which spun out of San Raffaele Telethon Institute for Gene Therapy...
BioCentury | Apr 20, 2020
Finance

French VC Sofinnova expanding start-up ecosystem in Italy with new local fund’s first investments

...NASDAQ:ORTX), the first ex vivo gene therapy to gain European approval, was developed by the San Raffaele Telethon Institute for Gene Therapy...
BioCentury | Sep 12, 2019
Financial News

Genenta’s series C marks start of Qianzhan’s European push

...there are still “great science and skills, and fewer investors.” Genenta spun out from the San Raffaele Telethon Institute for Gene Therapy...
BioCentury | May 28, 2019
Distillery Techniques

Raising lentiviral surface levels of CD47 to improve therapeutic index

...et al. Sci. Transl. Med. ; published online May 22, 2019 doi:10.1126/scitranslmed.aav7325 CONTACT: Alessio Cantore, San Raffaele Telethon Institute for Gene Therapy...
...University, Milan, Italy email: cantore.alessio@hsr.it CONTACT: Luigi Naldini, same affiliation as above email: naldini.luigi@hsr.it Sandi Wong Bioverativ Inc. San Raffaele Telethon Institute for Gene Therapy Sanofi Vita-Salute...
BioCentury | May 24, 2019
Finance

Europe: Some spots hotter than others

...Italian startups based on research coming out of Telethon. The charity’s research institutes include the San Raffaele Telethon Institute for Gene Therapy...
...Italy Harvard University, Cambridge, Mass. Johns Hopkins University, Baltimore, Md. National University of Singapore, Singapore San Raffaele Telethon Institute for Gene Therapy...
...Oxford, Oxford, U.K. Vivet Therapeutics, Paris, France Stephen Hansen, Associate Editor Harvard University Johns Hopkins University National University of Singapore San Raffaele Telethon Institute for Gene Therapy University...
BioCentury | May 22, 2019
Preclinical News

SR-Tiget-led team boosts ‘don’t eat me’ signals on viral vectors to improve efficacy

...acquire the anti-phagocytic signal CD47 from host cell membranes, a team led by researchers at San Raffaele Telethon Institute for Gene Therapy...
...for hemophilia A and B using the institute's lentiviral gene transfer technology. Sandi Wong, Staff Writer Bioverativ Inc. San Raffaele Telethon Institute for Gene Therapy Sanofi CD47 Factor...
BioCentury | Oct 18, 2018
Distillery Therapeutics

Cancer

...G. et al. Nat. Commun. ; published online July 24, 2018 doi:10.1038/s41467-018-05315-0 CONTACT: Bernhard Gentner, San Raffaele Telethon Institute for Gene Therapy...
...Milan, Italy email: gentner.bernhard@hsr.it CONTACT: Luigi Naldini, Vita-Salute San Raffaele University, Milan, Italy email: naldini.luigi@hsr.it Alicia Parker San Raffaele Telethon Institute for Gene Therapy San...
Items per page:
1 - 10 of 25